{"transactions":[{"id":751089,"issuer":{"id":690,"kind":"organization","name":"Lantheus Holdings, Inc.","symbol":"LNTH"},"owners":[{"id":41646,"kind":"person","name":"Ber Gerard","position":1,"cik":"0001762144","reported_name":"Ber Gerard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-03T20:44:22.000Z","date":"2026-05-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":381,"price":96.67,"value":36831.27,"ownership":{"direct":true},"balance_after":27118,"source":{"system":"sec-edgar","filing":"0002064832-26-000219","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1521036/000206483226000219/form4.xml","form_type":"4"}},{"id":774425,"issuer":{"id":690,"kind":"organization","name":"Lantheus Holdings, Inc.","symbol":"LNTH"},"owners":[{"id":41646,"kind":"person","name":"Ber Gerard","position":1,"cik":"0001762144","reported_name":"Ber Gerard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-18T20:35:03.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":4137,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":27499,"source":{"system":"sec-edgar","filing":"0002064832-26-000205","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1521036/000206483226000205/form4.xml","form_type":"4"}},{"id":1144904,"issuer":{"id":690,"kind":"organization","name":"Lantheus Holdings, Inc.","symbol":"LNTH"},"owners":[{"id":41646,"kind":"person","name":"Ber Gerard","position":1,"cik":"0001762144","reported_name":"Ber Gerard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-05-16T20:37:36.000Z","date":"2025-05-14","kind":"grant","planned":false,"acquired":true,"shares":4543,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4543,"derivative":{"exercise_price":78.81,"exercise_date":"2026-05-14","expiration_date":"2035-05-14","underlying":"Common Stock","underlying_shares":4543},"source":{"system":"sec-edgar","filing":"0001062993-25-009688","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1521036/000106299325009688/form4.xml","form_type":"4"}},{"id":1144903,"issuer":{"id":690,"kind":"organization","name":"Lantheus Holdings, Inc.","symbol":"LNTH"},"owners":[{"id":41646,"kind":"person","name":"Ber Gerard","position":1,"cik":"0001762144","reported_name":"Ber Gerard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-16T20:37:36.000Z","date":"2025-05-14","kind":"grant","planned":false,"acquired":true,"shares":2537,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":23362,"source":{"system":"sec-edgar","filing":"0001062993-25-009688","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1521036/000106299325009688/form4.xml","form_type":"4"}},{"id":1150454,"issuer":{"id":690,"kind":"organization","name":"Lantheus Holdings, Inc.","symbol":"LNTH"},"owners":[{"id":41646,"kind":"person","name":"Ber Gerard","position":1,"cik":"0001762144","reported_name":"Ber Gerard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-13T20:07:44.000Z","date":"2025-05-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":396,"price":81.74,"value":32369.04,"ownership":{"direct":true},"balance_after":20825,"source":{"system":"sec-edgar","filing":"0001062993-25-009231","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1521036/000106299325009231/form4.xml","form_type":"4"}},{"id":1433398,"issuer":{"id":690,"kind":"organization","name":"Lantheus Holdings, Inc.","symbol":"LNTH"},"owners":[{"id":41646,"kind":"person","name":"Ber Gerard","position":1,"cik":"0001762144","reported_name":"Ber Gerard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-14T20:56:30.000Z","date":"2024-08-12","kind":"sale","planned":true,"acquired":false,"shares":100,"price":97.78,"value":9778.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 7, 2024."}],"balance_after":21221,"source":{"system":"sec-edgar","filing":"0000950170-24-097147","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1521036/000095017024097147/ownership.xml","form_type":"4"}},{"id":1433397,"issuer":{"id":690,"kind":"organization","name":"Lantheus Holdings, Inc.","symbol":"LNTH"},"owners":[{"id":41646,"kind":"person","name":"Ber Gerard","position":1,"cik":"0001762144","reported_name":"Ber Gerard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-14T20:56:30.000Z","date":"2024-08-12","kind":"sale","planned":true,"acquired":false,"shares":4225,"price":97.1,"value":410247.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 7, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.75 to $97.72, inclusive. The reporting person undertakes to provide to LNTH any security holder of LNTH or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4."}],"balance_after":21321,"source":{"system":"sec-edgar","filing":"0000950170-24-097147","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1521036/000095017024097147/ownership.xml","form_type":"4"}},{"id":1433396,"issuer":{"id":690,"kind":"organization","name":"Lantheus Holdings, Inc.","symbol":"LNTH"},"owners":[{"id":41646,"kind":"person","name":"Ber Gerard","position":1,"cik":"0001762144","reported_name":"Ber Gerard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-14T20:56:30.000Z","date":"2024-08-12","kind":"sale","planned":true,"acquired":false,"shares":11175,"price":96.23,"value":1075370.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 7, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.75 to $96.74, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc. (\"LNTH\") any security holder of LNTH or the staff of the Securities and Exchange Commission (\"SEC\"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."}],"balance_after":25546,"source":{"system":"sec-edgar","filing":"0000950170-24-097147","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1521036/000095017024097147/ownership.xml","form_type":"4"}},{"id":1482879,"issuer":{"id":75095,"kind":"organization","name":"Y-mAbs Therapeutics, Inc.","symbol":"YMAB"},"owners":[{"id":41646,"kind":"person","name":"Ber Gerard","position":1,"cik":"0001762144","reported_name":"Ber Gerard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-11T19:54:20.000Z","date":"2024-06-10","kind":"sale","planned":false,"acquired":false,"shares":722,"price":12,"value":8664.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Nondiscretionary sale to cover tax liability associated with the vesting and settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $12.00 to $12.015, inclusive. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":1608,"source":{"system":"sec-edgar","filing":"0001104659-24-070533","document":"tm2417022-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1722964/000110465924070533/tm2417022-2_4seq1.xml","form_type":"4"}},{"id":1515658,"issuer":{"id":690,"kind":"organization","name":"Lantheus Holdings, Inc.","symbol":"LNTH"},"owners":[{"id":41646,"kind":"person","name":"Ber Gerard","position":1,"cik":"0001762144","reported_name":"Ber Gerard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-15T20:30:35.000Z","date":"2024-05-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":302,"price":77.88,"value":23519.76,"ownership":{"direct":true},"balance_after":36721,"source":{"system":"sec-edgar","filing":"0000950170-24-060532","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1521036/000095017024060532/ownership.xml","form_type":"4"}},{"id":1515657,"issuer":{"id":690,"kind":"organization","name":"Lantheus Holdings, Inc.","symbol":"LNTH"},"owners":[{"id":41646,"kind":"person","name":"Ber Gerard","position":1,"cik":"0001762144","reported_name":"Ber Gerard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-15T20:30:35.000Z","date":"2023-05-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":327,"price":94.82,"value":31006.14,"ownership":{"direct":true},"balance_after":37023,"source":{"system":"sec-edgar","filing":"0000950170-24-060532","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1521036/000095017024060532/ownership.xml","form_type":"4"}},{"id":1518819,"issuer":{"id":690,"kind":"organization","name":"Lantheus Holdings, Inc.","symbol":"LNTH"},"owners":[{"id":41646,"kind":"person","name":"Ber Gerard","position":1,"cik":"0001762144","reported_name":"Ber Gerard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-05-13T21:11:18.000Z","date":"2024-05-09","kind":"grant","planned":false,"acquired":true,"shares":4853,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4853,"derivative":{"exercise_price":75.9,"exercise_date":"2025-05-09","expiration_date":"2034-05-09","underlying":"Common Stock","underlying_shares":4853},"source":{"system":"sec-edgar","filing":"0000950170-24-058831","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1521036/000095017024058831/ownership.xml","form_type":"4"}},{"id":1518818,"issuer":{"id":690,"kind":"organization","name":"Lantheus Holdings, Inc.","symbol":"LNTH"},"owners":[{"id":41646,"kind":"person","name":"Ber Gerard","position":1,"cik":"0001762144","reported_name":"Ber Gerard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-13T21:11:18.000Z","date":"2024-05-09","kind":"grant","planned":false,"acquired":true,"shares":2635,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":37350,"source":{"system":"sec-edgar","filing":"0000950170-24-058831","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1521036/000095017024058831/ownership.xml","form_type":"4"}},{"id":1859978,"issuer":{"id":75095,"kind":"organization","name":"Y-mAbs Therapeutics, Inc.","symbol":"YMAB"},"owners":[{"id":41646,"kind":"person","name":"Ber Gerard","position":1,"cik":"0001762144","reported_name":"Ber Gerard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-06-09T18:02:50.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":13950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Stock options granted to the Reporting Person as a non-employee director pursuant to the 2018 Equity Incentive Plan of Y-mAbs Therapeutics, Inc."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock options vest in equal monthly installments during the first year following the date of grant, subject to the Reporting Person's continued service to Y-mAbs Therapeutics, Inc. on each vesting date and are exercisable immediately upon vesting."}],"balance_after":13950,"derivative":{"exercise_price":8.13,"expiration_date":"2033-06-08","underlying":"Common stock","underlying_shares":13950},"source":{"system":"sec-edgar","filing":"0001104659-23-070044","document":"tm2318348-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1722964/000110465923070044/tm2318348-4_4seq1.xml","form_type":"4"}},{"id":1859977,"issuer":{"id":75095,"kind":"organization","name":"Y-mAbs Therapeutics, Inc.","symbol":"YMAB"},"owners":[{"id":41646,"kind":"person","name":"Ber Gerard","position":1,"cik":"0001762144","reported_name":"Ber Gerard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-09T18:02:50.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":2330,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted to the Reporting Person as a non-employee director pursuant to the 2018 Equity Incentive Plan of Y-mAbs Therapeutics, Inc. Each RSU represents a contingent right to receive one share of the Issuer's common stock on the vesting date of the RSUs. The RSUs vest in full on the earlier of the first anniversary of the date of grant or the date immediately preceding the date of the Issuer's annual meeting of stockholders held in 2024, subject to the Reporting Person's continued service to Y-mAbs Therapeutics, Inc. on the vesting date."}],"balance_after":2330,"source":{"system":"sec-edgar","filing":"0001104659-23-070044","document":"tm2318348-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1722964/000110465923070044/tm2318348-4_4seq1.xml","form_type":"4"}},{"id":1893118,"issuer":{"id":690,"kind":"organization","name":"Lantheus Holdings, Inc.","symbol":"LNTH"},"owners":[{"id":41646,"kind":"person","name":"Ber Gerard","position":1,"cik":"0001762144","reported_name":"Ber Gerard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-05-15T22:35:34.000Z","date":"2023-05-11","kind":"grant","planned":false,"acquired":true,"shares":3798,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3798,"derivative":{"exercise_price":99.38,"exercise_date":"2024-05-11","expiration_date":"2033-05-11","underlying":"Common Stock","underlying_shares":3798},"source":{"system":"sec-edgar","filing":"0000899243-23-012991","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1521036/000089924323012991/doc4.xml","form_type":"4"}},{"id":1893117,"issuer":{"id":690,"kind":"organization","name":"Lantheus Holdings, Inc.","symbol":"LNTH"},"owners":[{"id":41646,"kind":"person","name":"Ber Gerard","position":1,"cik":"0001762144","reported_name":"Ber Gerard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-15T22:35:34.000Z","date":"2023-05-11","kind":"grant","planned":false,"acquired":true,"shares":2012,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":34715,"source":{"system":"sec-edgar","filing":"0000899243-23-012991","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1521036/000089924323012991/doc4.xml","form_type":"4"}},{"id":2205044,"issuer":{"id":75095,"kind":"organization","name":"Y-mAbs Therapeutics, Inc.","symbol":"YMAB"},"owners":[{"id":41646,"kind":"person","name":"Ber Gerard","position":1,"cik":"0001762144","reported_name":"Ber Gerard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Stock Option (right to buy)","published_at":"2022-07-19T13:21:18.000Z","date":"2022-07-15","kind":"grant","acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Stock options granted to the Reporting Person as a non-employee director pursuant to the 2018 Equity Incentive Plan of Y-mAbs Therapeutics, Inc."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options vest in equal monthly installments during the first year following the date of grant, subject to the Reporting Person's continued service to Y-mAbs Therapeutics, Inc., and are exercisable immediately upon vesting."}],"balance_after":16000,"derivative":{"exercise_price":16.64,"expiration_date":"2032-07-14","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001104659-22-080791","document":"tm2221312-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1722964/000110465922080791/tm2221312-3_4seq1.xml","form_type":"4"}},{"id":2273153,"issuer":{"id":690,"kind":"organization","name":"Lantheus Holdings, Inc.","symbol":"LNTH"},"owners":[{"id":41646,"kind":"person","name":"Ber Gerard","position":1,"cik":"0001762144","reported_name":"Ber Gerard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-05-12T21:51:17.000Z","date":"2022-05-06","kind":"grant","acquired":true,"shares":4068,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Form 4 originally filed on May 10, 2022 inadvertently reported 3,616 options granted on May 6, 2022 due to an administrative error. The correct amount of options granted on May 6, 2022 is 4,068 and is being reported in this amendment."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The Form 4 originally filed on May 10, 2022 inadvertently reported 3,616 options granted on May 6, 2022 due to an administrative error. The correct amount of options granted on May 6, 2022 is 4,068 and is being reported in this amendment."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The Form 4 originally filed on May 10, 2022 inadvertently reported 3,616 options granted on May 6, 2022 due to an administrative error. The correct amount of options granted on May 6, 2022 is 4,068 and is being reported in this amendment."}],"balance_after":4068,"derivative":{"exercise_price":64.2,"exercise_date":"2023-05-06","expiration_date":"2032-05-06","underlying":"Common Stock","underlying_shares":4068},"source":{"system":"sec-edgar","filing":"0000899243-22-017806","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1521036/000089924322017806/doc4a.xml","form_type":"4/A","original_submission_date":"2022-05-10"}},{"id":2273150,"issuer":{"id":690,"kind":"organization","name":"Lantheus Holdings, Inc.","symbol":"LNTH"},"owners":[{"id":41646,"kind":"person","name":"Ber Gerard","position":1,"cik":"0001762144","reported_name":"Ber Gerard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-12T21:25:45.000Z","date":"2022-05-10","kind":"sale","acquired":false,"shares":1277,"price":58.19,"value":74308.63,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Company withheld 1,277 shares to satisfy tax withholding obligations resulting from the vesting of restricted stock units."}],"balance_after":32703,"source":{"system":"sec-edgar","filing":"0000899243-22-017785","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1521036/000089924322017785/doc4.xml","form_type":"4"}},{"id":2275872,"issuer":{"id":690,"kind":"organization","name":"Lantheus Holdings, Inc.","symbol":"LNTH"},"owners":[{"id":41646,"kind":"person","name":"Ber Gerard","position":1,"cik":"0001762144","reported_name":"Ber Gerard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-05-10T20:39:18.000Z","date":"2022-05-06","kind":"grant","acquired":true,"shares":3616,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3616,"derivative":{"exercise_price":64.2,"exercise_date":"2023-05-06","expiration_date":"2032-05-06","underlying":"Common Stock","underlying_shares":3616},"source":{"system":"sec-edgar","filing":"0000899243-22-017449","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1521036/000089924322017449/doc4.xml","form_type":"4"}},{"id":2275871,"issuer":{"id":690,"kind":"organization","name":"Lantheus Holdings, Inc.","symbol":"LNTH"},"owners":[{"id":41646,"kind":"person","name":"Ber Gerard","position":1,"cik":"0001762144","reported_name":"Ber Gerard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-10T20:39:18.000Z","date":"2022-05-06","kind":"grant","acquired":true,"shares":2180,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units cliff vest on May 6, 2023."}],"balance_after":33980,"source":{"system":"sec-edgar","filing":"0000899243-22-017449","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1521036/000089924322017449/doc4.xml","form_type":"4"}},{"id":2669603,"issuer":{"id":75095,"kind":"organization","name":"Y-mAbs Therapeutics, Inc.","symbol":"YMAB"},"owners":[{"id":41646,"kind":"person","name":"Ber Gerard","position":1,"cik":"0001762144","reported_name":"Ber Gerard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Stock Option (right to buy)","published_at":"2021-06-14T17:03:48.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Stock options granted to the Reporting Person as a non-employee director pursuant to the 2018 Equity Incentive Plan of Y-mAbs Therapeutics, Inc."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options vest in equal monthly installments during the first year following the date of grant, subject to the Reporting Person's continued service on the board of directors of Y-mAbs Therapeutics, Inc., and are exercisable immediately upon vesting."}],"balance_after":16000,"derivative":{"exercise_price":37.53,"exercise_date":"2021-07-10","expiration_date":"2031-06-10","underlying":"Common stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001104659-21-080833","document":"tm2118093-14_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1722964/000110465921080833/tm2118093-14_4seq1.xml","form_type":"4"}},{"id":2715904,"issuer":{"id":690,"kind":"organization","name":"Lantheus Holdings, Inc.","symbol":"LNTH"},"owners":[{"id":41646,"kind":"person","name":"Ber Gerard","position":1,"cik":"0001762144","reported_name":"Ber Gerard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-12T20:30:53.000Z","date":"2021-05-10","kind":"grant","acquired":true,"shares":8513,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":31800,"source":{"system":"sec-edgar","filing":"0000899243-21-019271","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1521036/000089924321019271/doc4.xml","form_type":"4"}},{"id":3012520,"issuer":{"id":690,"kind":"organization","name":"Lantheus Holdings, Inc.","symbol":"LNTH"},"owners":[{"id":41646,"kind":"person","name":"Ber Gerard","position":1,"cik":"0001762144","reported_name":"Ber Gerard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-05T20:50:44.000Z","date":"2020-10-01","kind":"grant","acquired":true,"shares":1065,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"As previously disclosed, the Board of Directors of the Company elected to receive all remaining compensation payable in 2020 in the form of time-based restricted stock units, rather than in cash.  The transaction reported in this Form 4 reports the additional restricted stock units earned by the reporting person for the compensation payable in the fourth quarter of 2020, as calculated by the Company on October 1, 2020."}],"balance_after":23287,"source":{"system":"sec-edgar","filing":"0000899243-20-027275","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1521036/000089924320027275/doc4.xml","form_type":"4"}},{"id":3059868,"issuer":{"id":690,"kind":"organization","name":"Lantheus Holdings, Inc.","symbol":"LNTH"},"owners":[{"id":41646,"kind":"person","name":"Ber Gerard","position":1,"cik":"0001762144","reported_name":"Ber Gerard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-12T21:39:31.000Z","date":"2020-08-10","kind":"grant","acquired":true,"shares":741,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"As previously disclosed, including most recently in our Form 10-Q for the fiscal period ended June 30, 2020, the Board of Directors of the Company elected to receive all remaining compensation payable in 2020 in the form of time-based restricted stock units, rather than in cash.  The transaction reported in this Form 4 reports the additional restricted stock units earned by the reporting person for the compensation payable through the third quarter of 2020, as finally calculated by the Company on August 10, 2020."}],"balance_after":22222,"source":{"system":"sec-edgar","filing":"0000899243-20-022154","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1521036/000089924320022154/doc4.xml","form_type":"4"}},{"id":3100477,"issuer":{"id":75095,"kind":"organization","name":"Y-mAbs Therapeutics, Inc.","symbol":"YMAB"},"owners":[{"id":41646,"kind":"person","name":"Ber Gerard","position":1,"cik":"0001762144","reported_name":"Ber Gerard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Stock Option (right to buy)","published_at":"2020-06-24T16:47:17.000Z","date":"2020-06-23","kind":"grant","acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Stock options granted to the Reporting Person as a non-employee director pursuant to the 2018 Equity Incentive Plan of Y-mAbs Therapeutics, Inc."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options vest in equal monthly installments during the first year following the date of grant, subject to the Reporting Person's continued service on the board of directors of Y-mAbs Therapeutics, Inc., and are exercisable immediately upon vesting."}],"balance_after":16000,"derivative":{"exercise_price":48.67,"exercise_date":"2020-07-23","expiration_date":"2030-06-23","underlying":"Common stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001104659-20-076458","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1722964/000110465920076458/a4.xml","form_type":"4"}},{"id":3101610,"issuer":{"id":690,"kind":"organization","name":"Lantheus Holdings, Inc.","symbol":"LNTH"},"owners":[{"id":41646,"kind":"person","name":"Ber Gerard","position":1,"cik":"0001762144","reported_name":"Ber Gerard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2020-06-23T21:21:19.000Z","date":"2020-06-19","kind":"grant","acquired":true,"shares":17481,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Received in the Merger in exchange for a non-qualified stock option to acquire 56,393 shares of Progenics for $5.01 per share."}],"balance_after":17481,"derivative":{"exercise_price":16.17,"exercise_date":"2020-06-19","expiration_date":"2029-12-13","underlying":"Common stock","underlying_shares":17481},"source":{"system":"sec-edgar","filing":"0000899243-20-017493","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1521036/000089924320017493/doc4.xml","form_type":"4"}},{"id":3101609,"issuer":{"id":690,"kind":"organization","name":"Lantheus Holdings, Inc.","symbol":"LNTH"},"owners":[{"id":41646,"kind":"person","name":"Ber Gerard","position":1,"cik":"0001762144","reported_name":"Ber Gerard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-23T21:21:19.000Z","date":"2020-06-19","kind":"grant","acquired":true,"shares":15500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Received in exchange for 50,000 shares of Progenics Pharmaceuticals, Inc. (\"Progenics\"), in connection with the merger of Progenics pursuant to the Amended and Restated Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of February 20, 2020, by and among Lantheus Holdings, Inc. (the \"Company\"), Plato Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of the Company (\"Merger Sub\"), and Progenics, pursuant to which Merger Sub merged with and into Progenics, with Progenics surviving as a wholly owned subsidiary of the Company (the \"Merger\")."}],"balance_after":21481,"source":{"system":"sec-edgar","filing":"0000899243-20-017493","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1521036/000089924320017493/doc4.xml","form_type":"4"}},{"id":3101608,"issuer":{"id":690,"kind":"organization","name":"Lantheus Holdings, Inc.","symbol":"LNTH"},"owners":[{"id":41646,"kind":"person","name":"Ber Gerard","position":1,"cik":"0001762144","reported_name":"Ber Gerard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-23T21:21:19.000Z","date":"2020-06-19","kind":"grant","acquired":true,"shares":5981,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5981,"source":{"system":"sec-edgar","filing":"0000899243-20-017493","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1521036/000089924320017493/doc4.xml","form_type":"4"}},{"id":3102412,"issuer":{"id":148291,"kind":"organization","name":"PROGENICS PHARMACEUTICALS INC","symbol":"PGNX"},"owners":[{"id":41646,"kind":"person","name":"Ber Gerard","position":1,"cik":"0001762144","reported_name":"Ber Gerard","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-23T16:48:05.000Z","date":"2020-06-19","kind":"disposition_to_issuer","acquired":false,"shares":16393,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This option was originally scheduled to vest in annual installments over the five-year period beginning December 13, 2019 and became immediately vested upon the Merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"At the effective time of the Merger, this option was assumed by Lantheus and converted into an option to purchase Lantheus common stock based on an exchange ratio of 0.31 of a share of Lantheus common stock for each share of Progenics common stock subject to the option (with a corresponding adjustment being made to the exercise price of the option). Except for these adjustments, the other terms of the option continue in effect."}],"balance_after":0,"derivative":{"exercise_price":5.01,"expiration_date":"2029-12-13","underlying":"Common Stock","underlying_shares":16393},"source":{"system":"sec-edgar","filing":"0001437749-20-013676","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/835887/000143774920013676/rdgdoc.xml","form_type":"4"}},{"id":3102411,"issuer":{"id":148291,"kind":"organization","name":"PROGENICS PHARMACEUTICALS INC","symbol":"PGNX"},"owners":[{"id":41646,"kind":"person","name":"Ber Gerard","position":1,"cik":"0001762144","reported_name":"Ber Gerard","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-23T16:48:05.000Z","date":"2020-06-19","kind":"disposition_to_issuer","acquired":false,"shares":40000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the effective time of the Merger, this option was assumed by Lantheus and converted into an option to purchase Lantheus common stock based on an exchange ratio of 0.31 of a share of Lantheus common stock for each share of Progenics common stock subject to the option (with a corresponding adjustment being made to the exercise price of the option). Except for these adjustments, the other terms of the option continue in effect."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This option was originally scheduled to vest in annual installments over the five-year period beginning December 13, 2019 and became immediately vested upon the Merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"At the effective time of the Merger, this option was assumed by Lantheus and converted into an option to purchase Lantheus common stock based on an exchange ratio of 0.31 of a share of Lantheus common stock for each share of Progenics common stock subject to the option (with a corresponding adjustment being made to the exercise price of the option). Except for these adjustments, the other terms of the option continue in effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was originally scheduled to vest in annual installments over the five-year period beginning December 13, 2019 and became immediately vested upon the Merger."}],"balance_after":0,"derivative":{"exercise_price":5.01,"expiration_date":"2029-12-13","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001437749-20-013676","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/835887/000143774920013676/rdgdoc.xml","form_type":"4"}},{"id":3102410,"issuer":{"id":148291,"kind":"organization","name":"PROGENICS PHARMACEUTICALS INC","symbol":"PGNX"},"owners":[{"id":41646,"kind":"person","name":"Ber Gerard","position":1,"cik":"0001762144","reported_name":"Ber Gerard","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-06-23T16:48:05.000Z","date":"2020-06-19","kind":"disposition_to_issuer","acquired":false,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On June 19, 2020, pursuant to the Amended and Restated Agreement and Plan of Merger, dated February 20, 2020 (the \"Merger Agreement\") among Lantheus Holdings, Inc. (\"Lantheus\"), Plato Merger Sub, Inc., a wholly-owned subsidiary of Lantheus (\"Merger Sub\"), and Progenics Pharmaceuticals, Inc. (\"Progenics\"), Merger Sub merged with and into Progenics (the \"Merger\"), with Progenics surviving as a wholly-owned subsidiary of Lantheus. Pursuant to the Merger Agreement, each share of Progenics common stock was cancelled and converted into the right to receive (i) 0.31 of a share of Lantheus common stock (with such fraction of a Lantheus share having a market value of $4.60 on the effective date of the Merger) and (ii) one contingent value right (a \"CVR\") issued by Lantheus subject to and in accordance with the Contingent Value Rights Agreement, dated June 19, 2020, between Lantheus and Computershare Trust Company, N.A."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001437749-20-013676","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/835887/000143774920013676/rdgdoc.xml","form_type":"4"}},{"id":3339884,"issuer":{"id":148291,"kind":"organization","name":"PROGENICS PHARMACEUTICALS INC","symbol":"PGNX"},"owners":[{"id":41646,"kind":"person","name":"Ber Gerard","position":1,"cik":"0001762144","reported_name":"Ber Gerard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2019-12-17T15:14:27.000Z","date":"2019-12-13","kind":"grant","acquired":true,"shares":16393,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option becomes exercisable immediately on the date of grant."}],"balance_after":16393,"derivative":{"exercise_price":5.01,"exercise_date":"2019-12-13","expiration_date":"2029-12-13","underlying":"Common Stock","underlying_shares":16393},"source":{"system":"sec-edgar","filing":"0001562180-19-006144","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/835887/000156218019006144/primarydocument.xml","form_type":"4"}},{"id":3339883,"issuer":{"id":148291,"kind":"organization","name":"PROGENICS PHARMACEUTICALS INC","symbol":"PGNX"},"owners":[{"id":41646,"kind":"person","name":"Ber Gerard","position":1,"cik":"0001762144","reported_name":"Ber Gerard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2019-12-17T15:14:04.000Z","date":"2019-12-13","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"5yr 20% On Vest beginning on 13-Dec-2019"}],"balance_after":40000,"derivative":{"exercise_price":5.01,"expiration_date":"2029-12-13","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001562180-19-006143","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/835887/000156218019006143/primarydocument.xml","form_type":"4"}},{"id":3488984,"issuer":{"id":75095,"kind":"organization","name":"Y-mAbs Therapeutics, Inc.","symbol":"YMAB"},"owners":[{"id":41646,"kind":"person","name":"Ber Gerard","position":1,"cik":"0001762144","reported_name":"Ber Gerard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Stock Option (right to buy)","published_at":"2019-06-14T16:18:53.000Z","date":"2019-06-12","kind":"grant","acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Stock options granted to the Reporting Person as a non-employee director pursuant to the 2018 Equity Incentive Plan of Y-mAbs Therapeutics, Inc."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options vest in equal monthly installments during the first year following the date of grant, subject to the Reporting Person's continued service on the board of directors of Y-mAbs Therapeutics, Inc., and are exercisable immediately upon vesting."}],"balance_after":16000,"derivative":{"exercise_price":21.45,"exercise_date":"2019-07-12","expiration_date":"2029-06-12","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001104659-19-035672","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1722964/000110465919035672/a4.xml","form_type":"4"}}]}